R&D
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 1–12 of 117 articles
Quick answer
NovaPharmaNews R&D hub for FDA covers 117 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Adial Pharmaceuticals Completes Azora Merger, Expands Ulcerative Colitis Pipeline
Biotech’s coming of age: AI, capital efficiency and China reshape the field
Edgewise Therapeutics’ EDG-7500 clears key Phase 2 test
Celiac disease therapies enter a new era of innovation
Neumora navacaprant fails Phase 3 as EnGene cuts 50% of staff
Global hematology trials keep research patient-centered and regionally relevant
Hillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
Planning a successful pivot from lab to clinic: a practical career map
HFMA conference: Affordability was the focus, but fixes remained unclear
FDA Clears First OTC CGM for Children: Dexcom Expands Stelo
FDA authorizes generic nitenpyram for New World screwworm in pets
HHS responds coolly to alcohol risk paper amid cancer-warning debate
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.